These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Effects of a novel cardiotonic agent (+-)-6-[3-(3,4-dimethoxybenzylamino)-2-hydroxypropoxy]-2(1H)-quinolino ne (OPC-18790) on contractile force, cyclic AMP level, and aequorin light transients in dog ventricular myocardium. Endoh M, Kawabata Y, Katano Y, Norota I. J Cardiovasc Pharmacol; 1994 May; 23(5):723-30. PubMed ID: 7521454 [Abstract] [Full Text] [Related]
5. Pharmacological characterization of effects of UK-1745, a novel cardiotonic agent with beta-adrenoceptor-blocking action, in aequorin-loaded canine right ventricular muscle. Sawada H, Endoh M. J Mol Cell Cardiol; 1999 May; 31(5):1047-62. PubMed ID: 10336843 [Abstract] [Full Text] [Related]
6. Regulation of force and intracellular calcium transients by cyclic AMP generated by forskolin, MDL 17,043 and isoprenaline, and its modulation by muscarinic receptor agents: a novel mechanism for accentuated antagonism. Endoh M. Basic Res Cardiol; 1989 May; 84 Suppl 1():69-83. PubMed ID: 2554874 [Abstract] [Full Text] [Related]
8. Effects of new inotropic agents on cyclic nucleotide metabolism and calcium transients in canine ventricular muscle. Endoh M, Yanagisawa T, Taira N, Blinks JR. Circulation; 1986 Mar; 73(3 Pt 2):III117-33. PubMed ID: 2417745 [Abstract] [Full Text] [Related]
9. Dual regulation of myofilament Ca2+ sensitivity by levosimendan in normal and acidotic conditions in aequorin-loaded canine ventricular myocardium. Takahashi R, Endoh M. Br J Pharmacol; 2005 Aug; 145(8):1143-52. PubMed ID: 15951828 [Abstract] [Full Text] [Related]
11. Effects of a new 1,3-thiazole derivative ZSY-39 on force of contraction and cyclic AMP content in canine ventricular muscle. Endoh M, Satoh H, Norota I, Hirano K. Cardiovasc Drugs Ther; 1990 Aug; 4(4):1127-34. PubMed ID: 1964579 [Abstract] [Full Text] [Related]
12. Increase in myofibrillar Ca2+ sensitivity induced by UD-CG 212 Cl, an active metabolite of pimobendan, in canine ventricular myocardium. Takahashi R, Endoh M. J Cardiovasc Pharmacol; 2001 Feb; 37(2):209-18. PubMed ID: 11210003 [Abstract] [Full Text] [Related]
16. Ca2+ sensitizer Org-30029 reverses acidosis- and BDM-induced contractile depression in canine myocardium. Watanabe A, Tomoike H, Endoh M. Am J Physiol; 1996 Nov; 271(5 Pt 2):H1829-39. PubMed ID: 8945898 [Abstract] [Full Text] [Related]
17. Influence of the novel inotropic agent levosimendan on isometric tension and calcium cycling in failing human myocardium. Hasenfuss G, Pieske B, Castell M, Kretschmann B, Maier LS, Just H. Circulation; 1998 Nov 17; 98(20):2141-7. PubMed ID: 9815868 [Abstract] [Full Text] [Related]
18. Insulin-like growth factor-1 exerts Ca2+-dependent positive inotropic effects in failing human myocardium. von Lewinski D, Voss K, Hülsmann S, Kögler H, Pieske B. Circ Res; 2003 Feb 07; 92(2):169-76. PubMed ID: 12574144 [Abstract] [Full Text] [Related]
19. Endothelin 1 enhances myofilament Ca2+ responsiveness in aequorin-loaded ferret myocardium. Wang JX, Paik G, Morgan JP. Circ Res; 1991 Sep 07; 69(3):582-9. PubMed ID: 1873860 [Abstract] [Full Text] [Related]
20. Involvement of cyclic AMP in the positive inotropic effect of OPC-8212, a new cardiotonic agent, on the canine ventricular muscle. Yanagisawa T, Endoh M, Taira N. Jpn J Pharmacol; 1984 Nov 07; 36(3):379-88. PubMed ID: 6097725 [Abstract] [Full Text] [Related] Page: [Next] [New Search]